文献速递妇科

双侧输卵管卵巢切除术对I期低级别子宫内膜间质肉瘤绝经前患者总生存的影响:美国国家癌症数据库分析

Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis.
PubMed 文献 · Gynecol Oncol · 2020-04-27

基于美国国家癌症数据库2004-2015年数据,纳入743例≤50岁I期低级别子宫内膜间质肉瘤患者,其中72.8%行双侧输卵管卵巢切除术。行与未行该手术者5年总生存率分别为96.2%和97.1%,无统计学差异(P=0.50),校正合并症后HR为1.28(95%CI 0.51-3.19)。约三分之一患者保留卵巢功能,未观察到明确生存劣势。

要点

  • ≤50岁I期LGESS患者中72.8%行BSO,保留卵巢者占约三分之一。
  • BSO与保留卵巢者5年OS无差异(96.2% vs 97.1%,P=0.50)。
  • BSO与长期健康影响相关,特定I期LGESS患者可考虑保留卵巢。

核心结论

  • 在≤50岁I期低级别子宫内膜间质肉瘤患者中,双侧输卵管卵巢切除术未显示总生存获益。

研究设计与样本

  • 基于美国国家癌症数据库的回顾性队列分析,纳入2004-2015年诊断的743例≤50岁I期LGESS且行子宫切除术的患者。
  • 总生存分析纳入2004-2014年诊断且随访至少1个月的患者,采用Kaplan-Meier曲线和log-rank检验比较。

主要发现

  • 743例患者中位年龄44岁,541例(72.8%)行BSO。
  • 保留卵巢者更年轻(中位43 vs 45岁,P<0.001)、合并症更少(6.9% vs 12.4%,P=0.034)、行淋巴结清扫更少(30.7% vs 44.4%,P=0.001)。
  • 两组在亚分期或种族方面无差异。
  • 行BSO(n=490)与未行BSO(n=191)患者5年OS率分别为96.2%和97.1%,无差异(P=0.50)。
  • 校正合并症后,BSO与更好生存无关(HR 1.28,95%CI 0.51-3.19)。

临床怎么用

  • 对于≤50岁I期LGESS患者,可考虑在特定人群中保留卵巢功能,因BSO与长期健康影响相关且未显示总生存获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Investigate the prevalence of bilateral salpingo-oophorectomy (BSO) for women ≤50 years with early stage low-grade endometrial stromal sarcoma (LGESS) and its impact on overall survival (OS). METHODS: Women ≤50 years, diagnosed with stage I LGESS and managed with hysterectomy between 2004 and 2015 were identified from the National Cancer Database. Patient demographics were recorded and compared with the chi-square test. OS for patients diagnosed between 2004 and 2014 with at least one month of follow-up was assessed using Kaplan-Meier curves, and compared with the log-rank test. RESULTS: A total 743 patients with a median age of 44 years met the inclusion criteria. Use of radiatiotherapy (9%), chemotherapy (0.8%) and hormonal therapy (11%) was infrequent. BSO was performed in 541 (72.8%) patients. Patients who had ovarian preservation (OP) were younger (median age 43 vs 45 years, p < 0.001), less likely to have comorbidities (6.9% vs 12.4%, p = 0.034), or undergo LND (30.7% vs 44.4%, p = 0.001). There were no differences between the two groups in terms of substage or patient race. Five year OS rates for patients who did (n = 490) and did not (n = 191) undergo BSO were 96.2% and 97.1% and there was no difference in OS, p = 0.50. Even after controlling for presence of comorbidities performance of BSO was not associated with better survival (HR: 1.28, 95% CI: 0.51, 3.19). CONCLUSIONS: Ovarian function was preserved in approximately one third of women ≤50 years with stage I LGESS with no clear detriment to overall survival. As BSO is associated with long term health effects in this patient population OP could be considered in selected women with stage I LGESS.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Nasioudis D, Mastroyannis SA, Latif NA, et al. Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis. Gynecol Oncol. 2020. PMID: 32354469. doi:10.1016/j.ygyno.2020.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。